Navigation Links
IRIDEX Reports Third Quarter Financial Results
Date:11/19/2007

thin the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Act of 1934, as amended, relating to the Company's growth strategy and prospects, revenues, gross margins, and earnings, expenses, integrating the aesthetics business acquired from Laserscope and realizing efficiencies and synergies relating thereto, controlling costs, managing cash, and addressing our liquidity and capital resource needs. Actual results could differ materially and adversely from those projected in the forward-looking statements contained in our Quarterly Reports on Form 10-Q and Annual Report on Form 10-K for the fiscal year ended December 30, 2006 filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.

IRIDEX Corporation

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

(unaudited)

Three Months Ended Nine Months Ended

September September September September

29, 30, 29, 30,

2007* 2006 2007* 2006

Sales $13,575 $9,222 $41,390 $26,869

Cost of sales 7,390 4,350 23,412 13,076

Gross profit 6,185 4,872 17,978 13,793

Operating expenses:

Research and development 1,319 1,506 4,636 3,955

Sales, general and administrative 5,920 4,854 21,740 12,651

Total operating expenses 7,239 6,360 26,376 16,606

Income (loss) from operations (1,054) (1,488) (8,398) (2,813)

Legal settlement
'/>"/>

SOURCE IRIDEX Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. IRIDEX Announces Closing of $5.0 Million Private Placement
2. William Moore Appointed to IRIDEX Board of Directors
3. IRIDEX Appoints Burr, Pilger & Mayer New Independent Auditor
4. James B. Hawkins Appointed to IRIDEX Board of Directors
5. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
6. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... won," said Dr. Charmaine Yoest. ,, WASHINGTON...40-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemp...andates and funding in HR 3962 passed on the House...sident and CEO Dr. Charmaine Yoest said, "The pass...e Americans across this country who have flooded C...
(Date:11/8/2009)...Secure the Stability of Medicare ,, HOUSTON, N...table to: J. James Rohack, M.D., President, Americ...newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...eform bill, which will help improve the health sys...t passage of H.R. 3961 to secure the stability of ...
(Date:11/8/2009)...e Reform Bill ,, Critical legislation would s...cans ,, BALTIMORE, Nov. 7 /PRNewswire-USNewswi...of Representatives passed critical health care ref... seniors and end discrimination by insurance compa...rdable health coverage. ,, The Affordable Healt...
(Date:11/7/2009)...-- The American Medical Association (AMA) today aw... and Community Service to Manus C. Kraff, M.D., an...nizes physicians who have gone above and beyond th...ng public service contribution to their local comm...he opening session of the 2009 Interim Meeting of ...
(Date:11/7/2009)...- Members of the AMA are trying a last-minute tact... the AMA,s support of HR 3962. ,, "We want to ...ir PATIENTS, not the leadership of the AMA," said ...tion of American Physicians and Surgeons, and Take...s. ,, "If the AMA leadership ignores the publi...
Breaking Medicine News(10 mins):Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2
... in a House Foreign Affairs Committee Hearing on f...on, U.S. Rep. Chris Smith (R-N.J.) asked Secretary... overturn other countries pro-life laws and if the...tating, "We happen to think that family planning i...
...ial times, the cost of healthcare and how much we ...nomic concerns. The financial value of pain has a ...injury compensation. But what about on an individu...ter, and neuroscientists Ben Seymour and Raymond J...
... Sabertec , an emerging environmental technology...d to reduce CO2 emissions and toxic particulate ...easing fuel efficiency, took part in a press confe...mulus money from President Obama,s Energy Effici...
...sis and meds could put many at disadvantage, study...ay News) -- Black kidney patients may have more di...ment policy, researchers warn. , The Centers for M...eviously reimbursed separately. , Because black ki...
...April 22 Downey Regional Medical Center (DRMC) ha...ancial services to Cymetrix. Under the terms of t...s of the DRMC patient financial services function,...advanced technology, Cymetrix will transform DRMC,...
...alo Pharmaceutical, this week announced that it ha...ovident Bank to expand its operations. , , Headqu...-service, specialty pharmaceutical company. Halo p...ies. , , "Provident is a respected local bank th...
Other Medicine News:Health News:FRC Action: Obama Administration Working to Overturn Pro-Life Laws in Other Countries 2Health News:The price of pain and the value of suffering 2Health News:Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money 2Health News:Brockton Mayor, James E. Harrington Calls Press Conference to Unveil Newly Adopted Auto Emissions Technology Acquired With Federal Stimulus Money 3Health News:Downey Regional Medical Center Partners With Cymetrix to Implement Revenue Cycle Solutions 2Health News:Halo Pharmaceutical Completes $14.6 Million in Financing from The Provident Bank 2
(Date:11/6/2009)...wswire-FirstCall/ -- Boston Scientific Corporation... an agreement in principle with the U.S. Departmen...ssued by its Guidant subsidiary in 2005. The alle...ston Scientific,s 2006 acquisition of Guidant. ,...nvestigation by the U.S. Attorney,s Office in Minn...
(Date:11/6/2009)...e-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Na...ay, November 10, 2009 at 8:30 a.m. EST to discuss ...ess outlook for the remainder of 2009. Ron Bentsu...st the call. Keryx will announce its financial re...ued prior to the call. ,, In order to participa...
(Date:11/6/2009)...-FirstCall/ -- Caraco Pharmaceutical Laboratories,...omethamine ophthalmic solution, 0.5% following a f...tion (FDA) for Sun Pharma,s Abbreviated New Drug A...ic solution on the first day following patent expi...lly equivalent to Acular® Ophthalmic Solution...
Breaking Medicine Technology:Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 2Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 3Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 4Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 5Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 6Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 7Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 8Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 9Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 10Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 11Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 12Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 13Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 14Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 15Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 16Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant 17Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2CandleInTheWindow org Announces 241000 Scholarship Prize Winners 53375 1CandleInTheWindow org Announces 241000 Scholarship Prize Winners 53375 2Genes key to staph disease severity drug resistance found hitchhiking together 53372 1Genes key to staph disease severity drug resistance found hitchhiking together 53372 2Atlantic Plastic Surgery Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 53370 1Atlantic Plastic Surgery Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 53370 2Atlantic Plastic Surgery Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler 53370 3
...Apr 19, 2007 - Abraxis BioScience,Inc. (NASDAQ:AB...ny, discussed results from two pre-clinical studie...ngiogenesis and,rationale for combining nab-paclit...taxel protein-bound particles for injectable,suspe...like,bevacizumab (Avastin(R)) at the 98th American...
...Apr 19, 2007 - Abraxis BioScience,Inc. (NASDAQ:AB...ny, announced results from two pre-clinical studie... acidic and rich in,cysteine) expression in cancer... tumor-targeting technology at the 98th,American A...ng held,April 14-18, 2007 in Los Angeles., "Both p...
Other Medicine Technology:Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: